Biatain Super Non-Adhesive, Catalog number 46300, 10 pcs, REF 0463001400. Country of Origin:HU. ...
FDA Device Recall #Z-0138-2015 — Class III — September 8, 2014
Recall Summary
| Recall Number | Z-0138-2015 |
| Classification | Class III — Low risk |
| Date Initiated | September 8, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Coloplast Manufacturing US, LLC |
| Location | Minneapolis, MN |
| Product Type | Devices |
| Quantity | 6 |
Product Description
Biatain Super Non-Adhesive, Catalog number 46300, 10 pcs, REF 0463001400. Country of Origin:HU. Biatain Super Non-Adhesive dressing is primarily indicated for the treatment of high, medium and low exuding leg ulcers surrounded by fragile skin. The dressings may be used throughout the healing process to provide padding and protection for 2nd degree burns, diabetic wounds (primarily lower leg and foot), surgical wounds (left to heal by secondary intention and incisional wounds) and skin abrasions. The dressings are suitable for use under compression bandaging.
Reason for Recall
Coloplast is conducting a recall for one lot (4201931) of the Biatain Super Non-Adhesive wound dressing which was mislabeled.
Distribution Pattern
US Distribution to MO and RI.
Lot / Code Information
4201931
Other Recalls from Coloplast Manufacturing US, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0844-2025 | Class II | Folysil Silicone Foley Catheters, Device Refere... | Dec 2, 2024 |
| Z-0845-2025 | Class II | X-Flow prostatectomy catheter, Device Reference... | Dec 2, 2024 |
| Z-1463-2024 | Class II | Ureteral dilator, REF RBD014 | Mar 11, 2024 |
| Z-1360-2023 | Class II | Titan Pump Assembly, Catalog Number 5177701400;... | Mar 1, 2023 |
| Z-1366-2023 | Class II | Titan NB Scrotal Zero Ang 18cm, Catalog Number ... | Mar 1, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.